NO20015291L - Månedlige doser for behandling av Streptococcus pneumoniae- infeksjoner - Google Patents

Månedlige doser for behandling av Streptococcus pneumoniae- infeksjoner

Info

Publication number
NO20015291L
NO20015291L NO20015291A NO20015291A NO20015291L NO 20015291 L NO20015291 L NO 20015291L NO 20015291 A NO20015291 A NO 20015291A NO 20015291 A NO20015291 A NO 20015291A NO 20015291 L NO20015291 L NO 20015291L
Authority
NO
Norway
Prior art keywords
treatment
streptococcus pneumoniae
pneumoniae infections
monthly doses
monthly
Prior art date
Application number
NO20015291A
Other languages
English (en)
Norwegian (no)
Other versions
NO20015291D0 (no
Inventor
Thomas Reeves Parr
Margaret Mary Wasilewski
Michael Lee Zeckel
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO20015291D0 publication Critical patent/NO20015291D0/no
Publication of NO20015291L publication Critical patent/NO20015291L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20015291A 1999-05-03 2001-10-29 Månedlige doser for behandling av Streptococcus pneumoniae- infeksjoner NO20015291L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13225899P 1999-05-03 1999-05-03
PCT/US2000/008737 WO2000066144A2 (fr) 1999-05-03 2000-04-19 DOSES MENSUELLES DESTINEES AU TRAITEMENT DES INFECTIONS PAR $i(STREPTOCOCCUS PNEUMONIAE)

Publications (2)

Publication Number Publication Date
NO20015291D0 NO20015291D0 (no) 2001-10-29
NO20015291L true NO20015291L (no) 2001-12-17

Family

ID=22453188

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015291A NO20015291L (no) 1999-05-03 2001-10-29 Månedlige doser for behandling av Streptococcus pneumoniae- infeksjoner

Country Status (29)

Country Link
EP (1) EP1175222B1 (fr)
JP (1) JP2002543146A (fr)
KR (1) KR100757165B1 (fr)
CN (1) CN1349407A (fr)
AR (1) AR023827A1 (fr)
AT (1) ATE284702T1 (fr)
AU (1) AU774647B2 (fr)
BR (1) BR0010244A (fr)
CA (1) CA2372790A1 (fr)
CZ (1) CZ296127B6 (fr)
DE (1) DE60016734T2 (fr)
DZ (1) DZ3039A1 (fr)
EA (1) EA004295B1 (fr)
HK (1) HK1044707B (fr)
HR (1) HRP20010808A2 (fr)
HU (1) HUP0200940A3 (fr)
IL (2) IL145582A0 (fr)
MY (1) MY123542A (fr)
NO (1) NO20015291L (fr)
NZ (1) NZ514467A (fr)
PE (1) PE20010292A1 (fr)
PL (1) PL353444A1 (fr)
SK (1) SK285970B6 (fr)
SV (1) SV2002000065A (fr)
TR (1) TR200103211T2 (fr)
TW (1) TWI255716B (fr)
UA (1) UA73937C2 (fr)
WO (1) WO2000066144A2 (fr)
ZA (1) ZA200108013B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2337575T3 (pl) * 2008-08-30 2016-09-30 Sposoby leczenia z użyciem pojedynczych dawek orytawancyny
AU2013202360B2 (en) * 2008-08-30 2016-03-24 Melinta Therapeutics, Inc. Methods of treatment using single doses of oritavancin
US20160206688A1 (en) * 2013-08-26 2016-07-21 The Medicines Company Methods for treating bacteremia and osteomyelitis using oritavancin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives

Also Published As

Publication number Publication date
DE60016734T2 (de) 2005-12-08
ZA200108013B (en) 2003-03-26
UA73937C2 (en) 2005-10-17
PE20010292A1 (es) 2001-03-07
CN1349407A (zh) 2002-05-15
IL145582A (en) 2008-12-29
KR100757165B1 (ko) 2007-09-07
AU774647B2 (en) 2004-07-01
KR20020008173A (ko) 2002-01-29
TR200103211T2 (tr) 2002-02-21
NZ514467A (en) 2005-01-28
EP1175222A2 (fr) 2002-01-30
HK1044707A1 (en) 2002-11-01
MY123542A (en) 2006-05-31
HUP0200940A3 (en) 2002-10-28
WO2000066144A3 (fr) 2001-04-12
CA2372790A1 (fr) 2000-11-09
SV2002000065A (es) 2002-12-02
EP1175222B1 (fr) 2004-12-15
CZ20013949A3 (cs) 2002-07-17
SK15572001A3 (sk) 2003-05-02
DZ3039A1 (fr) 2004-03-27
CZ296127B6 (cs) 2006-01-11
NO20015291D0 (no) 2001-10-29
EA200101171A1 (ru) 2002-04-25
AR023827A1 (es) 2002-09-04
SK285970B6 (sk) 2007-12-06
HUP0200940A2 (en) 2002-08-28
HK1044707B (zh) 2005-09-30
EA004295B1 (ru) 2004-02-26
ATE284702T1 (de) 2005-01-15
IL145582A0 (en) 2002-06-30
DE60016734D1 (de) 2005-01-20
BR0010244A (pt) 2002-01-08
AU4329200A (en) 2000-11-17
TWI255716B (en) 2006-06-01
JP2002543146A (ja) 2002-12-17
HRP20010808A2 (en) 2002-12-31
WO2000066144A2 (fr) 2000-11-09
PL353444A1 (en) 2003-11-17

Similar Documents

Publication Publication Date Title
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
ITRM930591A0 (it) Dispositivo medico per la somministrazione di principi attivi o farmaci a bassissimo dosaggio, in particolare di farmaci omeopatici.
ATE307608T1 (de) Kombination von doctaxel und rhumab her2 zür krebsbehandlung
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
ATE219373T1 (de) Medikamente zur behandlung von autoimmunerkrankungen mit interferon-tau
DE69131014T2 (de) Rekombinante avirulente salmonella antifruchtbarkeitsimpfstoffe
DE69627147D1 (de) Orale zubereitung enthaltend zonula occludens toxin und einen biologisch aktiven wirkstoff sowie deren verwendung
DK1059934T3 (da) Matrixproteinpræparater til sårheling
HK1068606A1 (en) Novel aminobenzoephenones
MXPA05005338A (es) Metodos para administrar dalbavancin para el tratamiento de infecciones bacterianas.
SE9701161D0 (sv) New use I
ATE290548T1 (de) Expressionsblockierung von virulenten faktoren in s. aureus
ATE259654T1 (de) Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
DE69200711D1 (de) Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung.
DK0781560T3 (da) Anvendelse af immunoglobulinpræparater til fremstilling af et medikament til oral indgivelse til behandling og forebyggelse
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
NO20015291L (no) Månedlige doser for behandling av Streptococcus pneumoniae- infeksjoner
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
YU56702A (sh) Korišćenje fsh za lečenje neplodnosti
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
AR109456A2 (es) Uso de et743 para la preparación de un medicamento para el tratamiento de un paciente humano afectado por cáncer mediante terapia de combinación
IT7920742A0 (it) Poltrona per trattamento medico, in particolare poltrona odontoiatrica.
PT1150981E (pt) Composto nucleosidico terapeutico
ATE212839T1 (de) Hämoregulatorische verbindungen
UA79424C2 (en) Use of fsh for treatment of infertility in women

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application